In June 2013 Breakthrough hosted its second international conference on Triple Negative Breast Cancer.
Improving the limited treatment options and poor prognosis of patients with triple negative disease is a high priority for Breakthrough. This conference provided a comprehensive look at the challenges, controversies and breakthroughs in this disease, helping to provide patients with improved outcomes in future.
This conference built on the successful conference held in 2011 and highlighted novel laboratory approaches, innovative pre-clinical science and the latest clinical trial results. The aim was to discuss and advance our understanding of the aetiology, diagnosis and treatment of this challenging disease.
The 3 day programme covered all aspects of triple negative disease with invited plenary speakers and proffered abstracts presented as short talks or posters, creating a workshop atmosphere with ample opportunity for discussion and sharing expertise across disciplines.
The Conference has been awarded 15 category 1 (external) CPD credits by the Federation of the Royal Colleges of Physicians of the United Kingdom.
Professor Andrew Tutt
Professor of Oncology
Breakthrough Breast Cancer Research Unit, Guy’s Hospital
King’s College London School of Medicine